Does Farxiga Cause Yeast Infections?
Yes, Farxiga (dapagliflozin), an SGLT2 inhibitor for type 2 diabetes, heart failure, and chronic kidney disease, increases the risk of yeast infections, particularly genital ones like vulvovaginal candidiasis in women and balanitis or balanoposthitis in men. This occurs because the drug raises glucose levels in urine, creating an environment for yeast growth.[1][2]
How Common Are Yeast Infections with Farxiga?
Clinical trials showed genital mycotic infections in 8.5-10.8% of Farxiga users versus 2.7-3.7% on placebo. Rates were higher in women (up to 11%) than men (around 2%). Most cases were mild to moderate and resolved with antifungal treatment.[1][3]
Why Does Farxiga Raise Yeast Infection Risk?
Farxiga blocks glucose reabsorption in kidneys, causing glucosuria. Excess sugar in urine promotes yeast overgrowth, especially in uncircumcised men or those with poor hygiene. Risk factors include prior infections, obesity, or uncontrolled diabetes.[1][2]
What Do Patients Report About Yeast Infections?
User reviews on sites like Drugs.com note yeast infections as a frequent complaint, often starting within weeks of use. Women describe itching, burning, and discharge; men report redness and irritation. Switching to daily hygiene routines or antifungal creams helps many.[4]
How to Prevent or Manage Them on Farxiga?
Keep genital area clean and dry, wear cotton underwear, avoid tight clothing, and control blood sugar. Doctors often prescribe topical antifungals like clotrimazole proactively. Severe or recurrent cases may require pausing Farxiga or switching drugs.[1][2]
Compared to Other SGLT2 Inhibitors?
Farxiga's yeast infection risk matches Jardiance (empagliflozin) and Invokana (canagliflozin), all around 5-11% in trials. No SGLT2 inhibitor is exempt, but rates vary slightly by patient factors.[3]
When Should You See a Doctor?
Contact your doctor for symptoms like persistent itching, unusual discharge, pain during sex/urination, or swelling. Untreated infections can worsen or signal urinary tract issues.[1]
[1]: Farxiga Prescribing Information (FDA)
[2]: Mayo Clinic - Dapagliflozin Side Effects
[3]: NEJM - DAPA-HF Trial Data
[4]: Drugs.com - Farxiga User Reviews